Retrospective serological tests for determining the optimal blood concentration of voriconazole for treating fungal infection

Yakugaku Zasshi

Volumn 128, Issue 12, 2008, Pages 1811-1818

  Okuda, Toshikatsu ^a   Okuda, Akiko ^a   Watanabe, Noriko ^a   Takao, Masayoshi ^a   Takayanagi, Kazunobu ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Fungal infection; Optimal blood concentration; Serological test; Therapeutic drug monitoring (TDM); Trough blood concentration; Voriconazole (VRCZ)

Indexed keywords

AMPHOTERICIN B; ANTIGEN; ASPERGILLUS ANTIGEN; ITRACONAZOLE; MICAFUNGIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; AGED; ARTICLE; ASPERGILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; FEMALE; HALLUCINATION; HUMAN; LABORATORY TEST; LIVER DYSFUNCTION; MALE; MYCOSIS; NAUSEA; PATIENT MONITORING; SERODIAGNOSIS; SIDE EFFECT;

ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLUS; BETA-GLUCANS; BIOLOGICAL MARKERS; DRUG MONITORING; FEMALE; HUMANS; MALE; PYRIMIDINES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TRIAZOLES;

EID: 57149104429     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.1811     Document Type: Article

References (28)

1. Maesaki S., Iwakawa J., Higashiyama Y., Miyazaki Y., Yanagihara K., Tomono K., Tashiro T., Kohno S., J. Infect. Chemother., 6, 101-103 (2000).
2. Pfaller M. A., Messer S. A., Boyken L., Rice C., Tendolkal S., Hollis R. J., Doern G. V., Diekema D. J., J. Clin. Microbiol., 43, 2163-2167 (2005).
3. Pfaller M. A., Messer S. A., Boyken L., Hollis R. J., Rice C., Tendolkal S., Diekema D. J., Diagn. Microbiol. Infect. Dis., 48, 201-205 (2004).
4. Kohno S., Ogawa K., Kurashima A., Niki Y., Maesaki S., Jpn. J. Antibiot., 60, 321-334 (2007).
5. Dinning D. W., Rivaud P., Milpied N., Caillot D., Herbrecht R., Thiel E., Haas A., Ruhnke M., Lode H., Clin. Infect. Dis., 34, 563-571 (2002).
6. Herbrecht R., Denning D. W., Patterson T. F., Bennett J. E., Greene R. E., Oestmann J. W., Kern W. V., Marr K. A., Ribaud P., Lortholary O., Sylvester R., Rubin R. H., Wingard J. R., Stark P., Durand C., Caillot D., Thiel E., Chandrasekar P. H., Hodges M. R., Schlamm H. T., Troke P. F., Pauw B. D., N. Engl. J. Med., 347, 408-415 (2002).
7. Sabbatani S., Manfredi R., Pavoni M., Consales A., Chiodo F., Mycopathologia, 158, 165-171 (2004).
8. Guideline Compilation Commission for Fungal Disease, "Guideline for Diagnosing and Remedy of Fungal Disease," Ishiyaku Publishers, Inc., Tokyo, 2007.
9. Hyland R., Jones B. C., Smith D. A., Drug Metab. Dispos., 31, 540-547 (2003).
10. Shimizu T., Ochiai H., Asell F., Yokono Y., Kikuchi Y., Nitta M., Hama Y., Yamaguchi S., Hashimoto M., Taki K., Nakata K., Aida Y., Ohashi A., Ozawa N., Drug Metab. Pharmacokin., 18, 71-78 (2003).
11. Trifilio S., Oritiz R., Pennick G., Verma A., Pi J., Stosor V., Zembower T., Mehta J., Bone Marrow Transplant., 35, 509-513 (2005).
12. Walsh T. J., Anaissie E. J., Denning D. W., Herbrecht R., Kontoyiannis D. P., Marr K. A., Morrison V. A., Segal B. H., Steinbach W. J., Stevens D. A., van Burik J. A., Wingard J. R., Patterson T. F., Clin. Infect. Dis., 46, 327-360 (2008).
13. Andes D., Marchillo K., Stamstad T., Conklin R., Antimicrob. Agents Chemother., 47, 3165-3169 (2003).
14. Andes D., Lepak A., Nett J., Lincoln L., Marchillo K., Antimicrob. Agents Chemother., 50, 2384-2394 (2006).
15. Purkins L., Wood N., Ghahramani P., Greenhalgh K., Allen M. J., Kleinermans D., Antimicrob. Agents Chemother., 46, 2546-2553 (2002).
16. Tifilio S., Pennick G., Pi J., Zook J., Zook J., Golf M., Kaniecki K., Singhal S., Williams S., Winter J., Tallman M., Gordon L., Frankfurt O., Evens A., Mehta J., Cancer, 109, 1532-1535 (2007).
17. Marr K. A., Balajee S. A., McLaughlin L., Tabouret M., Bentsen C., Walsh T. J., J. Infect. Dis., 190, 641-649 (2004).
18. Maertens J. A., Klont R., Masson C., Theunissen K., Meersseman W., Lagrou K., Heinen C., Crepin B., Van Eldere J., Tabouret M., Donnelly J. P., Verweij P. E., Clin. Infect. Dis., 44, 1329-1336 (2007).
19. Boutboul F., Alberti C., Leblanc T., Sulahian A., Gluckman E., Derouin F., Ribaud P., Clin. Infect. Dis., 34, 939-943 (2002).
20. Anaissie E. J., Clin. Infect. Dis., 44, 1298-1306 (2007).
21. Ostrosky-Zeichner L., Alexander B. D., Kett D. H., Vazquez J., Pappas P. G., Saeki F., Ketchum P. A., Wingard J., Schiff R., Tamura H., Finkelman M. A., Rex J. H., Clin. Infect. Dis., 41, 654-659 (2005).
22. Pickering J. W., Sant H. W., Bowles C. A., Roberts W. L., Woods G. L., J. Clin. Microbiol., 43, 5957-5962 (2005).
23. Odabasi Z., Mattiuzzi G., Estey E., Kantarjian H., Saeki F., Ridge R. J., Ketchum P. A, Finkelman M. A., Rex J. H., Ostrosky-Zeichner L., Clin. Infect. Dis., 39, 199-205 (2005).
24. Horiguchi Y., Kansenshogaku Zasshi, 78, 566-573 (2004).
25. Common Terminology Criteria for Adverse Events v 3.0, Int. J. Clin. Oncol., 9, 1-82 (2004).
26. Usuki H., Inoue T., Ishida T., Miyazaki N., Med. Pharmacol., 53, 817-821 (2005).
27. Trifilio S., Singhal S., Williams S., Frankfurt O., Gordon L., Evens A., Winter J., Tallman M., Pi J., Mehta J., Bone Marrow Transplant., 40, 451-456 (2007).
28. Smith J., Safdar N., Knasinski V., Simmons W., Bhavnani S. M., Ambrose P. G., Andes D., Aintmicrob. Agents Chemother., 50, 1570-1572 (2006).